Galapagos | Lånekapital



Loan Capital Endring Dato
AstraZeneca USD 27.89B 154M 2025-03
Biogen USD 4.55B 1.4M 2024-12
Genmab DKK 937M 41M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
GRIFOLS EUR 8.68B 155.99M 2024-12
Hikma Pharmaceutical USD 1.06B 31M 2024-06
Incyte USD 32.64M 899K 2025-03
Merck EUR 6.37B 1.51B 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
UCB EUR 2.82B 166M 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Galapagos Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.